Daily non-political popular news in brief.

TXNIP -- Regulator of glucose homeostasis and potential diabetes drug target and more

Glucose homeostasis, the appropriate balancing of blood sugar levels, is impaired early in patients who become diabetic, causing life-threatening complications such as kidney failure and heart attacks. A study of the mechanisms of glucose homeostasis and early diabetes has dentified a key regulator of glucose homeostasis in humans.

Read more »

Keywords: txnip, regulator, glucose, homeostasis, potential, diabetes, drug, target, homeostasi, diabete

« Previous | Next »

Similar news on "TXNIP -- Regulator of glucose homeostasis and potential diabetes drug target and more":

1. Study identifies glucose 'sensor' that plays dual role in glucose metabolism and fat synthesis
   12-26-2006 · EurekAlert!
   In a new study, scientists at the Scripps Research Institute have described for the first time a glucose-activated sensor that acts as a switch to decrease production of endogenous glucose in the liver, and increase conversion of glucose to fat for storage in adipose tissue. This dual action makes the sensor, Liver X Receptor, a potential target for new therapies aimed at obesity and diabetes. The research may also have implications for heart disease and stroke.
   Similar news · Read more »
   
2. Insulin's brain impact links drugs and diabetes
   10-16-2007 · EurekAlert!
   Insulin, long known as an important regulator of blood glucose levels, now has a newly appreciated role in brain systems linked to drug addiction and neuropsychiatric disorders, according to a new report by researchers at Vanderbilt University Medical Center.
   Similar news · Read more »
   
3. Children's Hospital studying drug with the potential to prevent/delay onset of type 1 diabetes
   11-09-2007 · EurekAlert!
   Researchers at Children's Hospital of Pittsburgh of UPMC are participating in an international clinical trial currently underway to study the effectiveness of oral insulin in preventing or delaying the onset of type 1 diabetes in people at risk for the disease.
   Similar news · Read more »
   
4. Jefferson scientists find protein may be key in developing deadly form of pancreatic cancer
   10-11-2007 · EurekAlert!
   A tumor-blocking protein previously implicated in prostate and breast cancer development may also be behind the most aggressive type of pancreatic cancer. Researchers have discovered that the protein pp32 -- which normally applies the brakes on a cancer-causing gene -- is missing in an aggressive form of pancreatic cancer. Though the work is preliminary, the scientists say, the absent protein could eventually become a marker for the disease and a potential drug target.
   Similar news · Read more »
   
5. Other highlights in the Jan. 8 JNCI
   01-08-2008 · EurekAlert!
   Also in the Jan. 8 JNCI are an association between statin use and reduced cancer risk, a potential colon cancer drug target, a mouse model for studying kidney cancer, and a review of how tumor viruses regulate telomeres.
   Similar news · Read more »
   
6. Cholesterol drug hits diabetes with one-two punch, Tulane study says
   07-06-2007 · EurekAlert!
   Patients with type 2 diabetes may soon be able to control their glucose and their cholesterol levels with a single drug, according to a study led by Vivian A. Fonseca, professor of medicine and pharmacology at Tulane University School of Medicine and chief of the Tulane University Health Sciences Center Diabetes Program.
   Similar news · Read more »
   
7. Study reveals a key to blood vessel growth and possible drug target
   10-14-2007 · EurekAlert!
   Researchers have identified a molecular pathway that plays a critical role in the growth of blood vessels. The finding not only offers an important insight into the development of the vascular system during embryonic development but suggests a potential target for inhibiting the blood vessels that fuel cancers, diabetic eye complications and atherosclerosis, the researchers say.
   Similar news · Read more »
   
8. Jefferson scientists find protein potential drug target for treatment-resistant prostate cancer
   12-31-2007 · EurekAlert!
   Scientists at Jefferson's Kimmel Cancer Center in Philadelphia have found that a signaling protein that is key to prostate cancer cell growth is turned on in nearly all recurrent prostate cancers that are resistant to hormone therapy. If the findings hold up, the protein, called Stat5, may be a specific drug target against an extremely difficult-to-treat cancer.
   Similar news · Read more »
   
9. Jefferson scientists identify protein key to breast cancer spread, potential new drug target
   04-09-2007 · EurekAlert!
   Researchers at the Kimmel Cancer Center at Jefferson have identified a protein that they say is key to helping a quarter of all breast cancers spread. The finding, reported online the week of April 9, 2007, in the journal Proceedings of the National Academy of Sciences, could be a potential target for new drugs aimed at stopping or slowing the growth and progression of breast cancer.
   Similar news · Read more »
   
10. Weill Cornell team identifies potential new cancer drug target
    06-21-2007 · EurekAlert!
    Research led by scientists at Weill Cornell Medical College has uncovered two new potential points of vulnerability on a key cancer-promoting protein, called XIAP. Drugs that target either of these activities could help push cancer cells back into a more regular programmed cell death and thereby reduce or eliminate tumors.
    Similar news · Read more »